Illumina Ventures related stories
All articles and analysis
Kallyope snags $21 mlnNew York City-based Kallyope Inc., a biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, has secured $21 million in funding. The lead investor was Bill Gates. Other investors included Lux Capital, The Column Group, Polaris Partners, Illumina Ventures, Alexandria Venture Investments, Euclidean Capital and Two Sigma Ventures.
- Stilla Technologies attracts $18 mln Series A
Stilla Technologies, a European provider of digital PCR solutions for high precision genetic analysis, has closed $18 million in Series A financing. Illumina Ventures led the round with participation from Kurma Partners, LBO France, BNP Paribas Développement, Paris Saclay Seeds and Idinvest Partners. In addition to the financing, Nick Naclerio of Illumina Ventures, Philippe Peltier of Kurma Partners and Philippe Chambon of LBO France have joined Stilla's board of directors.
- Ribometrix scores $30 mln Series A
Durham, North Carolina-based Ribometrix, a biotechnology company, has closed $30 million in Series A financing. M Ventures led the round with participation from Amgen Ventures, Pappas Capital and Illumina Ventures. Founding investors SV Health Investors, AbbVie Ventures, Hatteras Venture Partners, MP Healthcare Venture Management, the Dementia Discovery Fund and Alexandria Venture Investments.
- SQZ Biotechnologies attracts $72 mln Series C
Massachusetts-based SQZ Biotechnologies, a cell therapy company, has raised $72 million in Series C financing. The investors included Everblue, Illumina Ventures, Invus, Orient Life, Viva Ventures Biotech Group, Bridger Healthcare Partners, Global Health Science Fund, GV, JDRF T1D Fund, NanoDimension and Polaris.
- Luna DNA inks $4 mln
Solana Beach, California-based Luna DNA, a community-owned genomic and medical research database, has raised $4 million in funding. The investors included Illumina Ventures, Arch Venture Partners, Bridgelink Capital and Hemisphere Ventures.
- Cernostics lands $2.5 mln
Pennsylvania-based Cernostics, a provider of next-generation cancer diagnostics and prognostics, has raised $2.5 million in Series A1 financing. Illumina Ventures led the round.
- Kallyope scores $66 mln Series B
New York City-based Kallyope Inc, a biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, has raised $66 million in Series B financing. The investors included Lux Capital, The Column Group, Polaris Partners, Illumina Ventures, Alexandria Venture Investments, Euclidean Capital and Two Sigma Ventures.
- Genome Medical collects more than $23 mln
San Francisco-based Genome Medical, a genomics medical practice, has raised more than $23 million in funding. The company's investors include GE Ventures, Kaiser Permanente Ventures, Illumina Ventures and Canaan Partners.
- NanoCollect Biomedical garners $10 mln Series B
San Diego-based NanoCellect Biomedical Inc, a developer of microfluidic cell sorting technologies for cell-based assays, has closed $10 million in Series B financing. The backers included Illumina Ventures, Anzu Partners, Vertical Venture Partners, 5 Prime Ventures, FusionX Ventures and Agilent Technologies.
Illumina Ventures raises $230mThe US venture capital firm closes inaugural fund above target.